NovoLog Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine
Condition:   Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus Interventions:   Drug: SAR341402;   Drug: insulin aspart;   Drug: insulin glargine (HOE901) Sponsor:   Sanofi Not yet recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2017 Category: Research Source Type: clinical trials